Header Logo

FULIANG CHU

TitleInstructor
InstitutionMD Anderson
DepartmentLymphoma-Myeloma
Address7455 Fannin St
Houston TX 77054-1901
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Chu F, Cao J, Liu J, Yang H, Davis TJ, Kuang SQ, Cheng X, Zhang Z, Karri S, Vien LT, Bover L, Sun R, Vega F, Green M, Davis RE, Neelapu SS. Chimeric antigen receptor T cells to target CD79b in B-cell lymphomas. J Immunother Cancer. 2023 11 24; 11(11). PMID: 38007239; PMCID: PMC10680003.
      Citations:    Fields:    Translation:HumansCells
    2. Liu S, Xie SM, Liu W, Gagea M, Hanker AB, Nguyen N, Singareeka Raghavendra A, Yang-Kolodji G, Chu F, Neelapu SS, Marchese A, Hanash S, Zimmermann J, Arteaga CL, Tripathy D. Targeting CXCR4 abrogates resistance to trastuzumab by blocking cell cycle progression and synergizes with docetaxel in breast cancer treatment. Breast Cancer Res. 2023 06 06; 25(1):62. PMID: 37280713; PMCID: PMC10245436.
      Citations: 1     Fields:    Translation:HumansAnimalsCells
    3. Liu S, Xie SM, Liu W, Gagea M, Hanker AB, Nguyen N, Raghavendra AS, Yang-Kolodji G, Chu F, Neelapu SS, Hanash S, Zimmermann J, Arteaga CL, Tripathy D. Targeting CXCR4 abrogates resistance to trastuzumab by blocking cell cycle progression and synergizes with docetaxel in breast cancer treatment. Res Sq. 2023 Feb 14. PMID: 36824840; PMCID: PMC9949251.
      Citations:    
    4. Nastoupil LJ, Chin CK, Westin JR, Fowler NH, Samaniego F, Cheng X, Ma MCJ, Wang Z, Chu F, Dsouza L, Obi C, Mims J, Feng L, Zhou S, Green M, Davis RE, Neelapu SS. Safety and activity of pembrolizumab in combination with rituximab in relapsed or refractory follicular lymphoma. Blood Adv. 2022 02 22; 6(4):1143-1151. PMID: 35015819; PMCID: PMC8864656.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    5. Plaks V, Rossi JM, Chou J, Wang L, Poddar S, Han G, Wang Z, Kuang SQ, Chu F, Davis RE, Vega F, Bashir Z, Jacobson CA, Locke FL, Reagan PM, Rodig SJ, Lekakis LJ, Flinn IW, Miklos DB, Bot A, Neelapu SS. CD19 target evasion as a mechanism of relapse in large B-cell lymphoma treated with axicabtagene ciloleucel. Blood. 2021 09 23; 138(12):1081-1085. PMID: 34041526; PMCID: PMC8462361.
      Citations: 9     Fields:    Translation:HumansCTClinical Trials
    6. Chu F, Li HS, Liu X, Cao J, Ma W, Ma Y, Weng J, Zhu Z, Cheng X, Wang Z, Liu J, Jiang ZY, Luong AU, Peng W, Wang J, Balakrishnan K, Yee C, Dong C, Davis RE, Watowich SS, Neelapu SS. CXCR5+CD8+ T cells are a distinct functional subset with an antitumor activity. Leukemia. 2019 11; 33(11):2640-2653. PMID: 31028278; PMCID: PMC6814517.
      Citations: 14     Fields:    Translation:HumansAnimalsCells
    7. Chu F, Cao J, Neelalpu SS. Versatile CAR T-cells for cancer immunotherapy. Contemp Oncol (Pozn). 2018 Mar; 22(1A):73-80. PMID: 29628798; PMCID: PMC5885071.
      Citations: 13     
    8. Mao F, Tu Q, Wang L, Chu F, Li X, Li HS, Xu W. Mesenchymal stem cells and their therapeutic applications in inflammatory bowel disease. Oncotarget. 2017 Jun 06; 8(23):38008-38021. PMID: 28402942; PMCID: PMC5514968.
      Citations: 33     Fields:    Translation:HumansCells
    9. Weng J, Moriarty KE, Baio FE, Chu F, Kim SD, He J, Jie Z, Xie X, Ma W, Qian J, Zhang L, Yang J, Yi Q, Neelapu SS, Kwak LW. IL-15 enhances the antitumor effect of human antigen-specific CD8+ T cells by cellular senescence delay. Oncoimmunology. 2016; 5(12):e1237327. PMID: 28123872; PMCID: PMC5215241.
      Citations: 11     Fields:    
    10. Li HS, Liu C, Xiao Y, Chu F, Liang X, Peng W, Hu J, Neelapu SS, Sun SC, Hwu P, Watowich SS. Bypassing STAT3-mediated inhibition of the transcriptional regulator ID2 improves the antitumor efficacy of dendritic cells. Sci Signal. 2016 09 27; 9(447):ra94. PMID: 27678219; PMCID: PMC5061503.
      Citations: 12     Fields:    Translation:AnimalsCells
    11. Voo KS, Foglietta M, Percivalle E, Chu F, Nattamai D, Harline M, Lee ST, Bover L, Lin HY, Baladandayuthapani V, Delgado D, Luong A, Davis RE, Kwak LW, Liu YJ, Neelapu SS. Selective targeting of Toll-like receptors and OX40 inhibit regulatory T-cell function in follicular lymphoma. Int J Cancer. 2014 Dec 15; 135(12):2834-46. PMID: 24771328; PMCID: PMC4352105.
      Citations: 13     Fields:    Translation:HumansCells
    12. Liu X, Chen X, Zhong B, Wang A, Wang X, Chu F, Nurieva RI, Yan X, Chen P, van der Flier LG, Nakatsukasa H, Neelapu SS, Chen W, Clevers H, Tian Q, Qi H, Wei L, Dong C. Transcription factor achaete-scute homologue 2 initiates follicular T-helper-cell development. Nature. 2014 Mar 27; 507(7493):513-8. PMID: 24463518; PMCID: PMC4012617.
      Citations: 158     Fields:    Translation:HumansAnimalsCells
    13. Chu F, Neelapu SS. Anti-PD-1 antibodies for the treatment of B-cell lymphoma: Importance of PD-1+ T-cell subsets. Oncoimmunology. 2014 Jan 01; 3(1):e28101. PMID: 24808975; PMCID: PMC4011813.
      Citations: 2     Fields:    
    14. Westin JR, Chu F, Zhang M, Fayad LE, Kwak LW, Fowler N, Romaguera J, Hagemeister F, Fanale M, Samaniego F, Feng L, Baladandayuthapani V, Wang Z, Ma W, Gao Y, Wallace M, Vence LM, Radvanyi L, Muzzafar T, Rotem-Yehudar R, Davis RE, Neelapu SS. Safety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients with relapsed follicular lymphoma: a single group, open-label, phase 2 trial. Lancet Oncol. 2014 Jan; 15(1):69-77. PMID: 24332512; PMCID: PMC3922714.
      Citations: 225     Fields:    Translation:HumansCTClinical Trials
    15. Rawal S, Chu F, Zhang M, Park HJ, Nattamai D, Kannan S, Sharma R, Delgado D, Chou T, Lin HY, Baladandayuthapani V, Luong A, Vega F, Fowler N, Dong C, Davis RE, Neelapu SS. Cross talk between follicular Th cells and tumor cells in human follicular lymphoma promotes immune evasion in the tumor microenvironment. J Immunol. 2013 Jun 15; 190(12):6681-93. PMID: 23686488; PMCID: PMC3680117.
      Citations: 38     Fields:    Translation:HumansCells
    16. Weng J, Rawal S, Chu F, Park HJ, Sharma R, Delgado DA, Fayad L, Fanale M, Romaguera J, Luong A, Kwak LW, Neelapu SS. TCL1: a shared tumor-associated antigen for immunotherapy against B-cell lymphomas. Blood. 2012 Aug 23; 120(8):1613-23. PMID: 22645177; PMCID: PMC3429305.
      Citations: 17     Fields:    Translation:HumansCells
    17. Chung Y, Tanaka S, Chu F, Nurieva RI, Martinez GJ, Rawal S, Wang YH, Lim H, Reynolds JM, Zhou XH, Fan HM, Liu ZM, Neelapu SS, Dong C. Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions. Nat Med. 2011 Jul 24; 17(8):983-8. PMID: 21785430; PMCID: PMC3151340.
      Citations: 508     Fields:    Translation:HumansAnimalsCells
    18. Liu J, Sun Y, Qi J, Chu F, Wu H, Gao F, Li T, Yan J, Gao GF. The membrane protein of severe acute respiratory syndrome coronavirus acts as a dominant immunogen revealed by a clustering region of novel functionally and structurally defined cytotoxic T-lymphocyte epitopes. J Infect Dis. 2010 Oct 15; 202(8):1171-80. PMID: 20831383; PMCID: PMC7537489.
      Citations: 57     Fields:    Translation:HumansAnimalsCells
    19. Chen W, Gao F, Chu F, Zhang J, Gao GF, Xia C. Crystal structure of a bony fish beta2-microglobulin: insights into the evolutionary origin of immunoglobulin superfamily constant molecules. J Biol Chem. 2010 Jul 16; 285(29):22505-12. PMID: 20444690; PMCID: PMC2903396.
      Citations: 11     Fields:    Translation:HumansAnimalsCells
    20. Qian X, Qi J, Chu F, Liu J, Li Q, Yan J. Crystallization and preliminary X-ray analysis of the V domain of human nectin-2. Acta Crystallogr Sect F Struct Biol Cryst Commun. 2009 Jun 01; 65(Pt 6):615-7. PMID: 19478445; PMCID: PMC2688424.
      Citations:    Fields:    Translation:HumansCells
    21. Chen Y, Gao F, Chu F, Peng H, Zong L, Liu Y, Tien P, Gao GF. Crystal structure of myeloid cell activating receptor leukocyte Ig-like receptor A2 (LILRA2/ILT1/LIR-7) domain swapped dimer: molecular basis for its non-binding to MHC complexes. J Mol Biol. 2009 Feb 27; 386(3):841-53. PMID: 19230061.
      Citations: 15     Fields:    Translation:HumansCells
    22. Ya T, Zhang Q, Chu F, Merritt J, Bilige M, Sun T, Du R, Zhang H. Immunological evaluation of Lactobacillus casei Zhang: a newly isolated strain from koumiss in Inner Mongolia, China. BMC Immunol. 2008 Nov 19; 9:68. PMID: 19019236; PMCID: PMC2596084.
      Citations: 25     Fields:    Translation:HumansAnimalsCells
    23. Khan AH, Chu F, Feng Y, Zhang Q, Qi J, Gao GF. Crystallization and preliminary crystallographic analysis of recombinant immunoglobulin G-binding protein from Streptococcus suis. Acta Crystallogr Sect F Struct Biol Cryst Commun. 2008 Aug 01; 64(Pt 8):757-9. PMID: 18678951; PMCID: PMC2494965.
      Citations:    Fields:    Translation:Cells
    24. Chen W, Chu F, Peng H, Zhang J, Qi J, Jiang F, Xia C, Gao F. Expression, purification, crystallization and preliminary X-ray diffraction analysis of grass carp beta2-microglobulin. Acta Crystallogr Sect F Struct Biol Cryst Commun. 2008 Mar 01; 64(Pt 3):200-2. PMID: 18323608; PMCID: PMC2374163.
      Citations: 2     Fields:    Translation:AnimalsCells
    25. Chen Y, Chu F, Gao F, Zhou B, Gao GF. Stability engineering, biophysical, and biological characterization of the myeloid activating receptor immunoglobulin-like transcript 1 (ILT1/LIR-7/LILRA2). Protein Expr Purif. 2007 Dec; 56(2):253-60. PMID: 17920929.
      Citations: 10     Fields:    Translation:HumansCells
    26. Chu F, Lou Z, Chen YW, Liu Y, Gao B, Zong L, Khan AH, Bell JI, Rao Z, Gao GF. First glimpse of the peptide presentation by rhesus macaque MHC class I: crystal structures of Mamu-A*01 complexed with two immunogenic SIV epitopes and insights into CTL escape. J Immunol. 2007 Jan 15; 178(2):944-52. PMID: 17202356.
      Citations: 19     Fields:    Translation:AnimalsCells
    27. Chu F, Lou Z, Gao B, Bell JI, Rao Z, Gao GF. Complex assembly, crystallization and preliminary X-ray crystallographic studies of rhesus macaque MHC Mamu-A*01 complexed with an immunodominant SIV-Gag nonapeptide. Acta Crystallogr Sect F Struct Biol Cryst Commun. 2005 Jun 01; 61(Pt 6):614-6. PMID: 16511111; PMCID: PMC1952337.
      Citations: 7     Fields:    Translation:AnimalsCells
    28. Xu D, Zhang Z, Jin L, Chu F, Mao Y, Wang H, Liu M, Wang M, Zhang L, Gao GF, Wang FS. Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase. Eur J Clin Microbiol Infect Dis. 2005 Mar; 24(3):165-71. PMID: 15789222; PMCID: PMC7088045.
      Citations: 56     Fields:    Translation:HumansCells
    29. Wang FS, Chu FL, Jin L, Li YG, Zhang Z, Xu D, Shi M, Wu H, Moulds JM. Acquired but reversible loss of erythrocyte complement receptor 1 (CR1, CD35) and its longitudinal alteration in patients with severe acute respiratory syndrome. Clin Exp Immunol. 2005 Jan; 139(1):112-9. PMID: 15606620; PMCID: PMC1809271.
      Citations: 9     Fields:    Translation:HumansCells
    30. Fan ZP, Wang FS, Xu DP, Chu FL, Shi M, Zhou Y, Zhang LX. [Detection of HBcAg-specific cytotoxic lymphocytes and their association with clinical status in patients with hepatitis B]. Zhonghua Yi Xue Za Zhi. 2004 Dec 17; 84(24):2073-6. PMID: 15730619.
      Citations: 1     Fields:    Translation:HumansCells
    31. Xu D, Zhang Z, Chu F, Li Y, Jin L, Zhang L, Gao GF, Wang FS. Genetic variation of SARS coronavirus in Beijing Hospital. Emerg Infect Dis. 2004 May; 10(5):789-94. PMID: 15200810; PMCID: PMC3323231.
      Citations: 13     Fields:    Translation:HumansCellsPHPublic Health
    32. Zhang Z, Wang FS, Zhao M, Liu JC, Xu DP, Jin L, Chen JM, Wang M, Chu FL. [Characterization of peripheral dendritic cell subsets and its implication in patients infected with severe acute respiratory syndrome]. Zhonghua Yi Xue Za Zhi. 2004 Jan 02; 84(1):22-6. PMID: 14990151.
      Citations: 6     Fields:    Translation:HumansCells
    33. Bypassing STAT3-mediated inhibition of the transcriptional regulator ID2 improves the antitumor efficacy of dendritic cells. Science Signaling. 9.
    34. Safety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients with relapsed follicular lymphoma. The Lancet Oncology. 15:69-77.
    35. IL-15 enhances the antitumor effect of human antigen-specific CD8+ T cells by cellular senescence delay. OncoImmunology. 5.
    36. Anti-PD-1 antibodies for the treatment of B-cell lymphoma. OncoImmunology. 3.
    37. Phase II clinical trail of patients with relapsed follicular lymphoma treated with a humanized antiprogrammed death-1 monoclonal antibody combined with rituximabrreport in the 54th ASH annual meeting. Journal of Leukemia and Lymphoma. 22:77-80.
    CHU's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (219)
    Explore
    _
    Co-Authors (22)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _